Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000598160 | SCV000706362 | uncertain significance | not provided | 2017-02-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000598160 | SCV001046517 | likely benign | not provided | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000598160 | SCV002601403 | uncertain significance | not provided | 2024-02-29 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign in association with Galloway-Mowat syndrome to our knowledge; This variant is associated with the following publications: (PMID: 33747040) |
Ce |
RCV000598160 | SCV004137533 | likely benign | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | WDR73: BP4 |
Prevention |
RCV004553325 | SCV004782737 | likely benign | WDR73-related disorder | 2021-05-31 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |